2 results
Approved WMOCompleted
Primary Objective:To evaluate the efficacy and safety of 2 doses of benralizumab in patients with moderate to very severe Chronic Pulmonary Disease (COPD).Secondary Objectives:To evaluate the effect of two doses of benralizumab on:* health status/…
Approved WMOWill not start
To assess the safety and reactogenicity of HB-101.To assess the immunogenicity of HB-101.